According to a new report, published by KBV research, The Global Hemodynamic Monitoring Devices Market size is expected to reach $1.9 billion by 2030, rising at a market growth of 5.4% CAGR during the forecast period. In the year 2022, the market attained a volume of 3184.1 thousand Units, experiencing a growth of 7.1% (2019-2022).
The Disposables segment is showcasing a CAGR of 5.9% during (2023 - 2030). The segment is growing because disposable parts are used in hemodynamic monitoring techniques for infection control and convenience. Compared to reusable components, disposables are more cost-effective, and the segment is witnessing an increase in disposable kits and accessories that are convenient and simple to use during hemodynamic monitoring procedures.
The Non-Invasive segment is leading Global Hemodynamic Monitoring Devices Market by System Type in 2022; thereby, achieving a market value of $1.0 Billion by 2030. One of the areas of recent developments in the field of blood pressure monitoring is the constant improvement in non-invasive continuous blood pressure measurement. These devices allow for real-time patient blood pressure monitoring and condition assessment. The cardiovascular parameters of patients are monitored using non-invasive hemodynamic devices in various clinical settings, including outpatient clinics, general wards, and home care.
The Catheterization Labs segment is exhibiting a CAGR of 5.8% during (2023 - 2030). The increase results from an increase in cardiac interventions, hospital catheterization lab space, and the use of minimally invasive cardiac treatments. These labs offer a variety of invasive surgical procedures, including coronary angiography, percutaneous coronary interventions (stent placement and angioplasty), and others, which involve the need for hemodynamic monitoring equipment. The segment is expected to proliferate in the coming years due to these benefits.
The North America region dominated the Global Hemodynamic Monitoring Devices Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $768.1 Million by 2030. The Europe region is estimated to grow at a CAGR of 5.2% during (2023 - 2030). Additionally, The Asia Pacific region would experience a CAGR of 6.2% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/hemodynamic-monitoring-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Edwards Lifesciences Corporation, GE HealthCare Technologies, Inc., Baxter International, Inc., ICU Medical, Inc., Masimo Corporation, Deltex Medical Group Plc., Sramek BioDynamics, Inc., Osypka Medical GmbH, Medtronic PLC, and Koninklijke Philips N.V.
By Product (Volume, Thousand Units, USD Million, 2019-2030)
By System Type (Volume, Thousand Units, USD Million, 2019-2030)
By End-use (Volume, Thousand Units, USD Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings 
